Approvals/TGA/ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial

Approved

STANDARD

ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial

Maxx Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ea03364751f6c57c
Product Name: ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial
Artg Id: 334814
Artg Name: ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial
Sponsor: Maxx Pharma Pty Ltd
Company Detail Path: /organization/maxx-pharma-pty-ltd
Artg Date: 2021-09-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/957c2c2864cbbe46ddc45aebb71d2f23.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e4c5fc4260647cc22c3dc5de567f6dd5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ea03364751f6c57c

Type

Standard